共 168 条
[1]
Pelosi E(2008)Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer Radiol Med 113 895-904
[2]
Arena V(2008)Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 253-263
[3]
Skanjeti A(2011)Diagnosis and therapy are walking together on radiopeptides’ avenue Eur J Nucl Med Mol Imaging 38 605-612
[4]
Pirro V(2015)18F-fluoromethylcholine or 18F-fluoroethylcholine PET for prostate cancer imaging: which is better? A literature revision Nucl Med Biol 42 340-348
[5]
Douroukas A(2014)Is radiocholine PET/CT already clinically useful in patients with prostate cancer? J Nucl Med 55 1401-1403
[6]
Pupi A(2015)Detection of local recurrence of prostate cancer: is there a role for early 18F FCH PET/CT? Ann Nucl Med 29 861-869
[7]
Husarik DB(2008)Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels Eur J Nucl Med Mol Imaging 35 1567-1569
[8]
Miralbell R(2001)Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer Cancer Res 61 110-117
[9]
Dubs M(2013)Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis Clin Nucl Med 38 305-314
[10]
John H(2009)Influence of trigger PSA and PSA kinetics on 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy J Nucl Med 50 1394-1400